#glp-1-drugs

[ follow ]
#alcoholism
more#alcoholism
#healthcare
fromFortune
5 days ago
Healthcare

How GoodRx CEO Wendy Barnes is trying to halve the cost of GLP-1 obesity drugs

fromFortune
5 days ago
Healthcare

How GoodRx CEO Wendy Barnes is trying to halve the cost of GLP-1 obesity drugs

more#healthcare
Health
fromWIRED
2 weeks ago

Eli Lilly's Obesity Pill Shows Promising Weight Loss in New Results

Eli Lilly's orforglipron offers an oral option with over 12% average weight loss for adults with obesity.
fromNew York Post
2 weeks ago

Former X CEO Linda Yaccarino lands new gig at digital health firm focused on weight loss drugs

Linda Yaccarino has been appointed CEO of eMed Population Health after leaving her role at X, focusing on technology in healthcare.
#weight-loss
fromFuturism
2 months ago
Alternative medicine

This Sleazy GLP-1 Prescription Site Is Using Deepfaked "Before-and-After" Photos of Fake Patients, and Running Ads Showing AI-Generated Ozempic Boxes

Wine
fromNew York Post
3 months ago

How much less Irish people drank while taking weight loss drugs like Ozempic: study

GLP-1 drugs like Ozempic aid weight loss and notably reduce alcohol consumption among users.
Wearables
fromwww.nytimes.com
3 months ago

How Ozempic is Shaping Weddings

Weight-loss medications like Zepbound are reshaping the wedding industry and conversations around body image, particularly for brides.
Alternative medicine
fromFuturism
2 months ago

This Sleazy GLP-1 Prescription Site Is Using Deepfaked "Before-and-After" Photos of Fake Patients, and Running Ads Showing AI-Generated Ozempic Boxes

MEDVi's marketing for GLP-1 drugs heavily relies on AI-generated images and fabricated testimonials, raising ethical concerns in patient health advertising.
more#weight-loss
#telehealth
fromAxios
2 weeks ago
Digital life

Former X CEO Linda Yaccarino named CEO of telehealth weight-loss drug company

fromWIRED
3 months ago
Alternative medicine

Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug

fromAxios
2 weeks ago
Digital life

Former X CEO Linda Yaccarino named CEO of telehealth weight-loss drug company

fromWIRED
3 months ago
Alternative medicine

Blocked From Selling Off-Brand Ozempic, Telehealth Startups Embrace a Less Effective Drug

more#telehealth
Health
fromwww.cnbc.com
2 weeks ago

Former X CEO Linda Yaccarino takes helm at digital health company eMed

Linda Yaccarino has been appointed CEO of eMed Population Health, focusing on GLP-1 population health management.
Public health
fromFuturism
1 month ago

Doctors Say Ozempic Is Wildly Effective at Helping Addicts Beat Cravings

GLP-1 drugs like Ozempic and Wegovy show promise as treatments for various addictions, gaining attention for their off-label use in rehabilitation settings.
fromBoston.com
1 month ago

America's protein obsession is transforming the dairy industry

"We ought to be thanking people who are buying whey protein at Aldi's," said Heiman, who, in addition to being a Master Cheesemaker, is Nasonville's CEO. "It definitely enhances the bottom line."
US news
fromInsideHook
1 month ago

Chinese Companies Are Developing Advanced GLP-1 Drugs

International collaboration is crucial in the research and development of new pharmaceuticals, particularly for diabetes and weight loss treatments.
fromInsideHook
1 month ago

Compounding Breaks Up Novo Nordisk-Hims & Hers Partnership

Compounded alternatives to GLP-1 drugs raise safety concerns and regulatory scrutiny.
#obesity
fromwww.npr.org
2 months ago
US news

Advice for trying GLP-1 drugs for weight loss from a doctor who's been there

Dr. Kessler emphasizes the impact of ultra-processed foods on obesity and discusses his personal journey with GLP-1 weight loss medications.
fromThe Atlantic
3 months ago
Public health

Who Should Really Be on Weight-Loss Drugs?

GLP-1 drugs should be prescribed based on a specific risk profile rather than just weight or obesity.
more#obesity
Growth hacking
fromFuturism
3 months ago

Weight Loss Influencer's Fans Angry When She Reveals How She Was Really Pulling It Off

Janelle Rohner faced backlash for not disclosing her weight loss drug use while promoting fat loss courses.
fromFast Company
3 months ago

What's actually driving the protein boom?

GLP-1 drugs like Ozempic and Wegovy are altering hunger signals in the brain, reshaping consumption patterns and redefining how we think about food.
Silicon Valley food
fromDigiday
3 months ago

Danone takes cues from pharma marketing as GLP-1 changes American appetites

Food brands are responding to GLP-1 drug usage by adapting product offerings and marketing strategies.
Danone's Oikos targets health-focused consumers using a multi-channel strategy influenced by pharmaceutical marketing.
fromBusiness Matters
3 months ago

Novo Nordisk cuts forecasts as Ozempic and Wegovy sales hit by US copycat versions

Novo Nordisk has lowered its revenue and profit forecasts due to sales pressure from unauthorized compounded GLP-1 drugs.
Wegovy is expected to see growth rebound after the FDA ban on compounded versions.
fromABC7 Los Angeles
3 months ago

WeightWatchers files for bankruptcy

The decisive actions we're taking today, with the overwhelming support of our lenders and noteholders, will give us the flexibility to accelerate innovation, reinvest in our members.
NYC startup
Wellness
fromThe Drum
4 months ago

GLP-1 didn't just upend Weight Watchers. It's exposing a wider brand dilemma

Weight Watchers files for bankruptcy, signaling a shift in weight loss approaches due to the rise of GLP-1 drugs.
[ Load more ]